Trial
NCT05469802
A Study of Purified Inactivated Zika Virus Vaccine (PIZV) in Healthy Adults
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Takeda
Collaborators
—
Condition
Healthy Volunteers
Intervention
Purified Inactivated Zika Virus Vaccine (PIZV)
Why stopped
Business reason, change in Zika virus epidemiology
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-13